Cargando…

Asian Pacific Society of Cardiology Consensus Recommendations on the Use of MitraClip for Mitral Regurgitation

Transcatheter mitral valve repair with the MitraClip, a catheter-based percutaneous edge-to-edge repair technique to correct mitral regurgitation (MR), has been demonstrated in Western studies to be an effective and safe MR treatment strategy. However, randomised clinical trial data on its use in As...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Khung Keong, Tan, Jack Wei Chieh, Muller, David WM, Walters, Darren L, Lindenfeld, JoAnn, Lee, Michael Kang Yin, Chui, Angus Shing Fung, Satish, Sai, Santoso, Teguh, Kubo, Shunsuke, Meng, John Chan Kok, Sin, Kenny YK, Ewe, See Hooi, Sim, David, Tay, Edgar, Meemook, Krissada, Sung, Shih-Hsien, Nguyen, Quang Ngoc, Pan, Xiangbin, Amaki, Makoto, Izumo, Masaki, Hayashida, Kentaro, Kim, Jung Sun, Kang, Do-Yoon, Stone, Gregg, Matsumoto, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218170/
https://www.ncbi.nlm.nih.gov/pubmed/34163538
http://dx.doi.org/10.15420/ecr.2021.01
Descripción
Sumario:Transcatheter mitral valve repair with the MitraClip, a catheter-based percutaneous edge-to-edge repair technique to correct mitral regurgitation (MR), has been demonstrated in Western studies to be an effective and safe MR treatment strategy. However, randomised clinical trial data on its use in Asian-Pacific patients is limited. Hence, the Asian Pacific Society of Cardiology convened an expert panel to review the available literature on MitraClip and to develop consensus recommendations to guide clinicians in the region. The panel developed statements on the use of MitraClip for the management of degenerative MR, functional MR, and other less common indications, such as acute MR, dynamic MR, hypertrophic obstructive cardiomyopathy, and MR after failed surgical repair. Each statement was voted on by each panel member and consensus was reached when 80% of experts voted ‘agree’ or ‘neutral’. This consensus-building process resulted in 10 consensus recommendations to guide general cardiologists in the evaluation and management of patients in whom MitraClip treatment is being contemplated.